CardioPractice Cardio Talk

With Filippo Crea, Gemelli Hospital, Rome - Italy, Konstantinos Toutouzas, National & Kapodistrian University of Athens, Athens - Greece and Marc Ferrini, CH Saint Joseph and Saint Luc, Lyon - France.
In this podcast, Filippo Crea and Konstantinos Toutouzas join Marc Ferrini to discuss the ESC and the Council for Cardiology Practice: actions and future directions for the cardiology of tomorrow.

With Dam-Huus, Copenhagen University Hospital, Copenhagen -  Denmark and Thomas Kumler, Steno Diabetes Center, Copenhagen, Herlev - Denmark.
In this podcast, Dam-Huus joins Thomas Kumler to discuss the invisible recovery after SCAD (spontaneous coronary artery dissection).
REFERENCE:
 
Dam-Huus KB, Palm P. After the dissection: the invisible recovery after SCAD (spontaneous coronary artery dissection). CardioPractice. https://www.escardio.org/communities/councils/cardiology-practice/education/cardiopractice/after-the-dissection:-the-invisible-recovery-after-SCAD-(spontaneous -coronary-artery-dissection)

With Mads Joensson Andersen, Aarhus University Hospital, Aarhus - Denmark and Thomas Kumler, Steno Diabetes Center, Copenhagen, Herlev -  Denmark. 
In this podcast, Mads Joensson Andersen joins Thomas Kumler to discuss chronic thromboembolic pulmonary hypertension.
REFERENCE:
1. Andersen S, Mellemkjaer S, Andersen MJ. Diagnosis and management of pulmonary hypertension due to left heart disease or pulmonary disease. CardioPractice. August 2026. https://www.escardio.org/communities/councils/cardiology-practice/education/cardiopractice/
diagnosis-and-management-of-pulmonary-hypertension-due-to-left-heart-disease-or-pulmonary-disease

With Riccardo Asteggiano, LARC (Laboratorio Analisi Ricerca Clinica), Turin - Italy and Marc Ferrini, CH Saint Joseph and Saint Luc, Lyon - France.
In this podcast, Riccardo Asteggiano joins Marc Ferrini to discuss Pulmonary hypertension due to left heart disease

With François Roubille, University Hospital Arnaud de Villeneuve, Montpellier - France and Ruxandra Christodorescu, University of Medicine and Pharmacy Victor Babes, Timisoara - Romania.
 
In this podcast, François Roubille joins Ruxandra Christodorescu  to discuss inflammation and coronary artery disease.
 
REFERENCES:
 
1.    Ridker PM, Everett BM, Thuren T, et al; CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017;377:1119-31. https://www.nejm.org/doi/10.1056/NEJMoa1707914
 
2.    Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019 Dec 26;381(26):2497-2505.
https://www.nejm.org/doi/10.1056/NEJMoa1912388
 
3.    Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med.;383:1838-1847.
https://www.nejm.org/doi/10.1056/NEJMoa2021372
 
4.    Tardif JC, Kouz S. Efficacy and safety of colchicine and spironolactone after myocardial infarction: the CLEAR-SYNERGY trial in perspective. Eur Heart J Acute Cardiovasc Care. 2024;13:843-4. https://academic.oup.com/ehjacc/article/13/12/843/7906243
 
5.    Byrne RA, Rossello X, Coughlan JJ, et al; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720-826. https://academic.oup.com/eurheartj/article/44/38/3720/7243210
 
6.    Vrints C, Andreotti F, Koskinas KC, et al; ESC Scientific Document Group. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415-3537. https://academic.oup.com/eurheartj/article/45/36/3415/7743115